Protect Pharmaceutical CorpProtect Pharmaceutical CorpProtect Pharmaceutical Corp

Protect Pharmaceutical Corp

No trades
See on Supercharts

PRTT fundamentals

Protect Pharmaceutical Corp financial statements, including revenue, expenses, profit, and loss

The total revenue of PRTT for the last quarter is 45.45 M USD, and it's 72.00% higher compared to the previous quarter. The net income of Q2 24 is 13.48 M USD.

Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth